Screener
INmune Bio INMB Q4 2025 Annual earnings
Reported March 30, 2026 · After market close
EPS-$0.18Beat by $0.09
Revenue estimate-$6.1K
EPS estimate-$0.27
Next report
Oct 29, 2026 (in 2 months)Revenue estimate$1.9M
EPS estimate-$0.15
Versus estimates
Revenue
Diluted EPS
FAQ
- When did INmune Bio report Q4 2025 earnings?
- INmune Bio (INMB) reported Q4 2025 earnings on March 30, 2026 after market close.
- What were INmune Bio's Q4 2025 revenue and EPS?
- INmune Bio reported eps of $-0.18 for Q4 2025.
- Did INmune Bio beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.27 by $0.09.
- How did INmune Bio's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 55.0% from $-0.40.
- Where can I find INmune Bio's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-26-036370) directly on SEC EDGAR. The filing index links above go to sec.gov.
